KLSE:IHH

Stock Analysis Report

IHH Healthcare Berhad

Executive Summary

IHH Healthcare Berhad, an investment holding company, provides healthcare services worldwide.

Snowflake

Fundamentals

Reasonable growth potential with adequate balance sheet.


Similar Companies

Share Price & News

How has IHH Healthcare Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

1.9%

IHH

1.8%

MY Healthcare

0.6%

MY Market


1 Year Return

13.1%

IHH

9.6%

MY Healthcare

-6.4%

MY Market


Shareholder returns

IHHIndustryMarket
7 Day1.9%1.8%0.6%
30 Day1.9%1.4%-1.3%
90 Day-0.5%-1.4%-5.7%
1 Year13.7%13.1%10.4%9.6%-3.1%-6.4%
3 Year-8.5%-9.8%-10.0%-11.8%2.5%-9.4%
5 Year21.3%18.2%18.8%14.6%1.4%-16.2%

Price Volatility Vs. Market

How volatile is IHH Healthcare Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is IHH Healthcare Berhad undervalued compared to its fair value and its price relative to the market?

23.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: IHH (MYR5.77) is trading below our estimate of fair value (MYR7.51)

Significantly Undervalued: IHH is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: IHH is poor value based on its PE Ratio (83.4x) compared to the Healthcare industry average (34x).

PE vs Market: IHH is poor value based on its PE Ratio (83.4x) compared to the MY market (14.4x).


Price to Earnings Growth Ratio

Low PEG Ratio: IHH is poor value based on its PEG Ratio (3.3x)


Price to Book Ratio

PB vs Industry: IHH is good value based on its PB Ratio (2.1x) compared to the MY Healthcare industry average (2.2x).


Next Steps

Future Growth

How is IHH Healthcare Berhad forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?

24.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IHH's forecast earnings growth (24.9% per year) is above the savings rate (2.7%).

Earnings vs Market: IHH's earnings (24.9% per year) are forecast to grow faster than the MY market (10.5% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: IHH's revenue (9.8% per year) is forecast to grow faster than the MY market (5.8% per year).

High Growth Revenue: IHH's revenue (9.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has IHH Healthcare Berhad performed over the past 5 years?

-9.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: IHH's earnings have declined by -9.9% per year over the past 5 years.

Accelerating Growth: IHH's earnings growth over the past year (81.8%) exceeds its 5-year average (-9.9% per year).

Earnings vs Industry: IHH earnings growth over the past year (81.8%) exceeded the Healthcare industry 9.7%.


Return on Equity

High ROE: IHH's Return on Equity (1.9%) is considered low.


Return on Assets

ROA vs Industry: IHH's Return on Assets is below or equal to the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: IHH has improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is IHH Healthcare Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: IHH's short term assets (MYR7.9B) exceeds its short term liabilities (MYR6.6B)

Long Term Liabilities: IHH's short term assets (7.9B) do not cover its long term liabilities (11.1B)


Debt to Equity History and Analysis

Debt Level: IHH's debt to equity ratio (32.8%) is considered satisfactory

Reducing Debt: IHH's debt to equity ratio has increased from 20.6% to 32.8% over the past 5 years.

Debt Coverage: IHH's debt is well covered by operating cash flow (21.4%).

Interest Coverage: IHH's interest payments on its debt are well covered by EBIT (6.1x coverage).


Balance Sheet

Information is not available.

Information is not available.


Next Steps

Dividend

What is IHH Healthcare Berhad's current dividend yield, its reliability and sustainability?

0.52%

Current Dividend Yield


Dividend Yield vs Market

company0.5%marketbottom25%2.1%markettop25%4.9%industryaverage0.7%forecastin3Years0.7%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: IHH's dividend (0.52%) isn’t notable compared to the bottom 25% of dividend payers in the MY market (2.06%).

High Dividend: IHH's dividend (0.52%) is low compared to the top 25% of dividend payers in the MY market (4.95%).

Stable Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are stable.

Growing Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: IHH is not paying a notable dividend for .


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IHH's dividend in 3 years as they are not forecast to pay a notable one for the MY market.


Next Steps

Management

What is the CEO of IHH Healthcare Berhad's salary, the management and board of directors tenure and is there insider trading?

2.6yrs

Average management tenure


CEO

See Leng Tan (54yo)

5.8yrs

Tenure

RM36,175,000

Compensation

Dr. See Leng Tan serves as the Group Chief Executive Officer and Managing Director at Parkway Pantai Limited. Dr. Tan serves as an Advisor at Clearbridge Accelerator. He has been the Chief Executive Office ...


CEO Compensation Analysis

Information is not available.

Compensation vs Earnings: See Leng's compensation has been consistent with company performance over the past year.


Management Age and Tenure

2.6yrs

Average Tenure

54yo

Average Age

Experienced Management: IHH's management team is considered experienced (2.6 years average tenure).


Board Age and Tenure

2.5yrs

Average Tenure

56yo

Average Age

Experienced Board: IHH's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellRM16,949,99708 Oct 19
Mehmet Aydinlar
EntityIndividual
Role
Unit Chairman
Shares3,000,000
Max PriceRM5.65

Ownership Breakdown


Management Team

  • Soon Teck Low (54yo)

    Group Chief Financial Officer

    • Tenure: 3.8yrs
  • See Leng Tan (54yo)

    CEO, MD & Non-Independent Executive Director

    • Tenure: 5.8yrs
    • Compensation: RM36.18m
  • Mehmet Aydinlar (62yo)

    • Tenure: 0yrs
    • Compensation: RM7.72m
  • Boon Kheng Chan (51yo)

    Group Head of Strategic Planning & Business Development (M&A) and CEO of South East Asia Ops. Div.

    • Tenure: 1.8yrs
  • Suet Wun Lim (59yo)

    Group Chief Operating Officer

    • Tenure: 1.6yrs
  • Ching Voon Seow

    Company Secretary

    • Tenure: 0yrs
  • Nili Shayrina Saat (44yo)

    Head of Risk Management

    • Tenure: 0.9yrs
  • Kelvin Loh (45yo)

    Executive Director

    • Tenure: 0.3yrs
  • Abdul Baba (63yo)

    President of IMU Health Sdn Bhd and C.E.O. & Vice-Chancellor of IMU Education Sdn Bhd

    • Tenure: 3.8yrs
  • Sharon Lin (50yo)

    Group Chief Human Resources Officer

    • Tenure: 2.6yrs

Board Members

  • Shirish Apte (66yo)

    Independent Non-Executive Director

    • Tenure: 5.1yrs
    • Compensation: RM722.00k
  • Mohammed Bin Hashim (62yo)

    Independent Non Executive Chairman

    • Tenure: 1.8yrs
    • Compensation: RM985.00k
  • See Leng Tan (54yo)

    CEO, MD & Non-Independent Executive Director

    • Tenure: 5.8yrs
    • Compensation: RM36.18m
  • Mehmet Aydinlar (62yo)

    • Tenure: 0yrs
    • Compensation: RM7.72m
  • Jill Watts (60yo)

    Independent Non Executive Director

    • Tenure: 1.5yrs
    • Compensation: RM337.00k
  • Koji Nagatomi (58yo)

    Non Independent & Non Executive Director

    • Tenure: 2.5yrs
    • Compensation: RM295.00k
  • Rossana Binti Ahmad Rashid (53yo)

    Independent Non-Executive Director

    • Tenure: 7.5yrs
    • Compensation: RM867.00k
  • Kelvin Loh (45yo)

    Executive Director

    • Tenure: 0.3yrs
  • Takeshi Saito (47yo)

    Non-Independent & Non-Executive Director

    • Tenure: 0.6yrs
    • Compensation: RM148.00k
  • Chinta Bhagat (50yo)

    Non-Independent Non-Executive Director

    • Tenure: 3.1yrs
    • Compensation: RM626.00k

Company Information

IHH Healthcare Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IHH Healthcare Berhad
  • Ticker: IHH
  • Exchange: KLSE
  • Founded: 2010
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: RM50.626b
  • Shares outstanding: 8.77b
  • Website: https://www.ihhhealthcare.com

Number of Employees


Location

  • IHH Healthcare Berhad
  • Pantai Hospital Kuala Lumpur
  • Level 11, Block A
  • Kuala Lumpur
  • Wilayah Persekutuan
  • 59100
  • Malaysia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IHHKLSE (Bursa Malaysia)YesOrdinary SharesMYMYRJul 2012
Q0FSGX (Singapore Exchange)YesOrdinary SharesSGSGDJul 2012
IHHH.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJul 2012

Biography

IHH Healthcare Berhad, an investment holding company, provides healthcare services worldwide. The company operates in seven segments: Singapore, Malaysia, India, North Asia, Acibadem Holdings, IMU Health,  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 14:58
End of Day Share Price2019/10/14 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.